[1] Minniti G, Scaringi C, Lanzetta G, et al. Standard (60 Gy) or short-course (40 Gy) irradiation plus concomitant and adjuvant temozolomide for elderly patients with glioblastoma:a propensity-matched analysis[J]. Int J Radiat Oncol Biol Phys, 2015, 91(1):109-115. [2] Hegi ME, Diserens AC, Gorlia T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma[J]. N Engl J Med, 2005, 352(10):997-1003. [3] Griffiths LA, Smith GE. Metabolism of apigenin and related compounds in the rat. Metabolite formation in vivo and by the intestinal microflora in vitro[J]. Biochem J, 1972, 128(4):901-911. [4] Voskresensky ON, Levitsky AP. QSAR aspects of flavonoids as a plentiful source of new drugs[J]. Curr Med Chem, 2002, 9(14):1367-1383. [5] Jung SK, Lee KW, Kim HY, et al. Myricetin suppresses UVB-induced wrinkle formation and MMP-9 expression by inhibiting Raf[J]. Biochem Pharmacol, 2010, 79(10):1455-1461. [6] Knickle A, Fernando W, Greenshields AL, et al. Myricetin-induced apoptosis of triple-negative breast cancer cells is mediated by the iron-dependent generation of reactive oxygen species from hydrogen peroxide[J]. Food Chem Toxicol, 2018, 118:154-167. [7] Maggioni D, Nicolini G, Rigolio R, et al. Myricetin and naringenin inhibit human squamous cell carcinoma proliferation and migration in vitro[J]. Nutr Cancer, 2014, 66(7):1257-1267. [8] Shih YW, Wu PF, Lee YC, et al. Myricetin suppresses invasion and migration of human lung adenocarcinoma A549 cells:possible mediation by blocking the ERK signaling pathway[J]. J Agric Food Chem, 2009, 57(9):3490-3499. [9] Ko CH, Shen SC, Lee TJ, et al. Myricetin inhibits matrix metalloproteinase 2 protein expression and enzyme activity in colorectal carcinoma cells[J]. Mol Cancer Ther, 2005, 4(2):281-290. [10] Lee JH, Choi YJ, Park SH, et al. Potential role of nucleoside diphosphate kinase in myricetin-induced selective apoptosis in colon cancer HCT-15cells[J]. Food Chem Toxicol, 2018, 116:315-322. [11] Vukovic NL, Obradovic AD, Vukic MD, et al. Cytotoxic, proapoptotic and antioxidative potential of flavonoids isolated from propolis against colon (HCT-116) and breast (MDA-MB-231) cancer cell lines[J]. Food Res Int, 2018, 106:71-80. [12] Zhang XH, Chen SY, Tang L, et al. Myricetin induces apoptosis in HepG2 cells through Akt/p70S6K/bad signaling and mitochondrial apoptotic pathway[J]. Anticancer Agents Med Chem, 2013, 13(10):1575-1581. [13] Zhang XH, Zou ZQ, Xu CW, et al. Myricetin induces G2/M phase arrest in HepG2 cells by inhibiting the activity of the cyclin B/Cdc2 complex[J]. Mol Med Rep, 2011, 4(2):273-277. [14] Park H, Park S, Bazer FW, et al. Myricetin treatment induces apoptosis in canine osteosarcoma cells by inducing DNA fragmentation, disrupting redox homeostasis, and mediating loss of mitochondrial membrane potential[J]. J Cell Physiol,2018,233(9):7457-7466. [15] Shimmyo Y, Kihara T, Akaike A, et al. Multifunction of myricetin on A beta:neuroprotection via a conformational change of A beta and reduction of A beta via the interference of secretases[J]. J Neurosci Res, 2008, 86(2):368-377. [16] 臧宝霞, 金鸣, 吴伟,等.杨梅素对血小板活化因子拮抗的作用[J]. 药学学报, 2003(11):831-833. [17] 钟正贤, 陈学芬, 周桂芬,等.西藤茶中杨梅树皮素降血糖的实验研究[J]. 中国现代应用药学, 2003, 20(6):466-468. [18] Bennett CJ, Caldwell ST, McPhail DB, et al. Potential therapeutic antioxidants that combine the radical scavenging ability of myricetin and the lipophilic chain of vitamin E to effectively inhibit microsomal lipid peroxidation[J]. Bioorg Med Chem, 2004, 12(9):2079-2098. [19] Grenier D, Chen H, Ben Lagha, et al. Dual action of Myricetin on Porphyromonas gingivalis and the inflammatory response of host cells:A promising therapeutic molecule for periodontal diseases[J]. PLoS One, 2015,10(6):e0131758. [20] Weng CJ, Yen GC. Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities[J]. Cancer Metastasis Rev, 2012, 31(1/2):323-351. [21] Kapoor C, Vaidya S, Wadhwan V, et al. Seesaw of matrix metalloproteinases (MMPs)[J]. J Cancer Res Ther, 2016, 12(1):28-35. [22] Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases:Regulators of the tumor microenvironment[J]. Cell, 2010, 141(1):52-67. [23] Sounni NE, Paye A, Host L, et al. MT-MMPS as regulators of vessel stability associated with angiogenesis[J]. Front Pharmacol, 2011, 2:111. |